Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

被引:0
|
作者
Mentz, R. [1 ]
Anker, S. [2 ]
Pitt, B. [3 ]
Rossing, P. [4 ]
Ruilope, L. [5 ,6 ]
Gebel, M. [7 ]
Kolkhof, P. [8 ]
Lawatscheck, R. [9 ]
Rohwedder, K. [10 ]
Bakris, G. [11 ]
机构
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Charite Univ Med Berlin, Dept Cardiol CVK, German Heart Ctr Charite, Berlin, Germany
[3] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[4] Steno Diabet Ctr, Herlev, Denmark
[5] Inst Res Imas12, Cardiorenal Translat Lab, Madrid, Spain
[6] Inst Res Imas12, Hypertens Unit, Madrid, Spain
[7] Bayer AG, Stat & Data Insights, Wuppertal, Germany
[8] Bayer AG, Res & Early Dev, Wuppertal, Germany
[9] Bayer AG, Clin Res, Wuppertal, Germany
[10] Bayer AG, Med Affairs, Wuppertal, Germany
[11] Univ Chicago Med, Dept Med, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis
    Mentz, Robert J.
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Gebel, Martin
    Kolkhof, Peter
    Lawatscheck, Robert
    Rohwedder, Katja
    Bakris, George L.
    FIDELIO-DKD FIGARO-DKD Investigators
    EUROPEAN JOURNAL OF HEART FAILURE, 2025,
  • [2] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN HISPANIC PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Rosas, Sylvia
    Ruilope, Luis M.
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Bonfanti, Andres A. C.
    Correa-Rotter, Ricardo
    Gonzalez, Fernando
    Pergola, Pablo
    Umpierrez, Guillermo
    Scalise, Andrea
    Scott, Charlie
    Joseph, Amer
    Bakris, George L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S47 - S48
  • [3] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN BLACK PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Flack, John M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Alder, Sharon
    Fried, Linda
    Jamerson, Kenneth
    Toto, Robert
    Brinker, Meike
    Farjat, Alfredo E.
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S20 - S20
  • [4] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [5] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
    Filippatos, Gerasimos
    Anker, Stefan D.
    August, Phyllis
    Coats, Andrew J. S.
    Januzzi, James L.
    Mankovsky, Boris
    Rossing, Peter
    Ruilope, Luis M.
    Pitt, Bertram
    Sarafidis, Pantelis
    Teerlink, John R.
    Kapelios, Chris J.
    Gebel, Martin
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Bakris, George
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 183 - 191
  • [6] Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis
    Pitt, Bertram
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Ruilope, Luis
    Herzog, Charles A.
    Greenberg, Barry
    Pecoits-Filho, Roberto
    Lambelet, Marc
    Lawatscheck, Robert
    Scalise, Andrea
    Filippatos, Gerasimos
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 11 (01) : 10 - 19
  • [7] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
  • [8] A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes
    Bakris, George L.
    Ruilope, Luis M.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Fried, Linda
    Roy-Chaudhury, Prabir
    Sarafidis, Pantelis
    Ahlers, Christiane
    Brinker, Meike
    Joseph, Amer
    Lawatscheck, Robert
    Agarwal, Rajiv
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 196 - 206
  • [9] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes
    Bansal, S.
    Anker, S.
    Bakris, G.
    Filippatos, G.
    Rossing, P.
    Ruilope, L.
    Birne, R.
    Canziani, M.
    Farjat, A.
    Brinker, M.
    Pitt, B.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [10] Efficacy and safety of finerenone in chronic kidney disease and type 2 diabetes patients: a systematic review and meta-analysis
    Yasmin, Farah
    Aamir, Muhammad
    Najeeb, Hala
    Atif, Abdul Raafe
    Siddiqui, Abdul Hannan
    Ahsan, Muhammad Nadeem
    Moeed, Abdul
    Ali, Syed Hasan
    Tahir, Haya Muhammad
    Asghar, Muhammad Sohaib
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (10): : 4973 - 4980